By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436


SEARCH JOBS


Industry
Pharmaceutical






Company News
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce Marketing Approval Of RIZAPORT For Migraines In Luxembourg 4/13/2017 9:48:55 AM
IntelGenx Corp. Files Preliminary Short Form Prospectus In Connection With A Proposed Offering Of Convertible Unsecured Debentures 4/6/2017 8:41:37 AM
IntelGenx Corp. Announces Development And Commercialization Agreement With Endo Ventures 12/27/2016 1:32:55 PM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce Definitive Agreement For Commercialization Of Rizaport For Migraines With Pharmatronic Co. In South Korea 12/14/2016 9:34:17 AM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Pharmatronic Co. For Korea 9/21/2016 8:40:08 AM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Grupo JUSTE For Spain And Additional Potential Territories 4/4/2016 9:11:59 AM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Grupo JUSTE For Spain And Additional Potential Territories 3/30/2016 9:07:42 AM
IntelGenx Corp. Announces USPTO Has Granted Patent Protecting RIZAPORT Oral Film For Migraines 2/18/2016 10:37:59 AM
IntelGenx Corp. Files Loxapine Oral Film Patent For Schizophrenia 2/10/2016 11:26:05 AM
IntelGenx Corp. Announces Creation Of A Scientific Advisory Board 2/4/2016 11:03:40 AM
12345678910...
//-->